/About Us

A trusted industry partner dedicated to supporting independent, community-based practices.

Our Mission

To partner with and empower community-based rheumatology practices by providing innovative solutions to optimize patient access and outcomes.

Our Vision

American Rheumatology Network (ARN) is a trusted industry partner that develops and improves solutions to guide future decision making in rheumatology with clinically driven data to yield financial and clinical value to rheumatology practices.

Our Values

Integrity

We adhere to honest, strong, and moral principles with our shareholders, employees, and partners.

Dependability

We accept responsibility for honest and ethical conduct towards our shareholders, employees, and the rheumatology community in which we operate.

Relationships

We are committed to our customers and partners by developing innovative solutions to meet evolving market needs.

Compassion

We aim to understand our partner’s situations and offer support.

Flexibility

We embrace and adapt to industry changes and partner needs by providing a diverse range of solutions to enhance practice efficiencies.

Meet The Team

Chief Executive Officer
Vice President of Finance
Strategic Account Manager
Strategic Account Manager
Director of Revenue Cycle
Service Account Coordinator
Director of Marketing
Events + Marketing Specialist

Industry Partners

Thank you to the following organizations for supporting ARN year round! These organizations deliver life saving medications to practices across the nation with the same goals in mind: to reduce cost, enhance healthcare and advance rheumatology.

Platinum

Organon

The Organon Biosimilars team is focused on providing a customer experience that prioritizes your goals throughout the entire biosimilar experience. We believe that helping more people access biologic therapies is important, and we are working toward that ambition with an unwavering commitment to you.  

Diamond

Johnson and Johnson

At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured. Where treatments are smarter and less invasive. And solutions are personal.

GSK

GSK is a science-led global healthcare company with a special purpose: to help people. We research, develop, and manufacture innovative pharmaceutical, biological, vaccine, and consumer healthcare products in an effort to bring differentiated, high-quality products to the people who need them.

Gold

AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer.
We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
aurinia
Aurinia Pharmaceuticals is a commercial stage biopharmaceutical company focused on developing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. 
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience.
ucb

We are a global biopharmaceutical company committed to innovation to improve the lives of people with neurological and immunological diseases, finding solutions to meet their unique needs. 

Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. 

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

teva
We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,600 products in nearly every therapeutic area.

Join our network

Learn more about our commitment to guide future decision making in rheumatology with clinically-driven data to yield financial and clinical value to your practice.

MENU

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.